Susan Knudson
Chief Executive Officer at HISTOGEN INC.
Net worth: - $ as of 31/03/2024
Profile
Susan A.
Knudson currently works at Histogen, Inc., as President, CEO, COO, CFO & Secretary from 2023 and Freedom Dogs, as Director.
Ms. Knudson also formerly worked at Ionis Pharmaceuticals, Inc., as Assistant Director-Accounting in 2000, Avera Pharmaceuticals, Inc., as Senior Director-Finance & Administration from 2002 to 2009, MD Edge, Inc., as Director-Finance & Administration from 2000 to 2002, CombiChem, Inc., as Controller, General Atomics, Inc., as Principal, Deloitte & Touche, as Principal, Histogen, Inc., as Chief Financial Officer, Secretary & Executive VP, Neothetics, Inc., as Chief Financial Officer from 2014 to 2017, Pfenex, Inc., as Chief Financial & Officer & Senior Vice President from 2018 to 2019, and Evofem Biosciences, Inc., as Chief Financial Officer.
Ms. Knudson received her undergraduate degree in 1987 from the University of San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HISTOGEN INC.
-.--% | 10/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Susan Knudson active positions
| Companies | Position | Start |
|---|---|---|
| HISTOGEN INC. | Chief Executive Officer | 01/10/2023 |
| Freedom Dogs | Director/Board Member | - |
Former positions of Susan Knudson
| Companies | Position | End |
|---|---|---|
| PFENEX INC. | Director of Finance/CFO | 13/11/2019 |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/01/2017 |
Avera Pharmaceuticals, Inc.
 Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/01/2009 |
| MD Edge, Inc. | Director of Finance/CFO | 01/04/2002 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2000 |
Training of Susan Knudson
| University of San Diego | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| EVOFEM BIOSCIENCES, INC. | Health Technology |
| HISTOGEN INC. | Health Technology |
| Private companies | 9 |
|---|---|
CombiChem, Inc.
 CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services CombiChem, Inc. used to provide computational drug recovery services to accelerate the discovery process for new drugs and chemical compounds. The company was founded in 1994 and headquartered in San Diego, CA | Commercial Services |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Health Services |
General Atomics, Inc.
 General Atomics, Inc. Electrical ProductsProducer Manufacturing General Atomics develops and manufactures high-technology products for commercial, and government applications. It offers nuclear fuel cycle, electromagnetic systems, remotely operated surveillance aircraft, airborne sensors, and high-power lasers. The company was founded in 1955 and is headquartered in San Diego, CA. | Producer Manufacturing |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Commercial Services |
| MD Edge, Inc. | |
Histogen, Inc. /Old/
 Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA. | Health Services |
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
| Freedom Dogs |
- Stock Market
- Insiders
- Susan Knudson
